Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activity-based Tools for Interrogating Host Biology During Infection. | Isr J Chem | 2023 | 37744997 | PubTator, text mining | PubMed |
| Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly. | World J Gastroenterol | 2023 | 37744296 | PubTator, text mining | PubMed |
| A CCL2+DPP4+ subset of mesenchymal stem cells expedites aberrant formation of creeping fat in humans. | Nat Commun | 2023 | 37730641 | PubTator, text mining | PubMed |
| Remimazolam and serious adverse events: A scoping review. | Eur J Anaesthesiol | 2023 | 37727906 | PubTator, text mining | PubMed |
| Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. | Cell Adh Migr | 2023 | 37726886 | PubTator, text mining | PubMed |
| Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study. | Diabetologia | 2023 | 37725107 | PubTator, text mining | PubMed |
| Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC. | Mol Cell Proteomics | 2023 | 37716475 | PubTator, text mining | PubMed |
| An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1). | Chem Biol Interact | 2023 | 37716419 | PubTator, text mining | PubMed |
| Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. | Clin Pharmacokinet | 2023 | 37715926 | PubTator, text mining | PubMed |
| Insights into vitamin A in bladder cancer, lack of attention to gut microbiota? | Front Immunol | 2023 | 37711628 | PubTator, text mining | PubMed |
| Human protozoa infection and dysplasia in ulcerative colitis: a neglected aspect in a prominent disease. | Parasitol Res | 2023 | 37710023 | PubTator, text mining | PubMed |
| Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer. | J Immunother Cancer | 2023 | 37709296 | PubTator, text mining | PubMed |
| Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants. | Clin Transl Sci | 2023 | 37688349 | PubTator, text mining | PubMed |
| RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia. | J Exp Clin Cancer Res | 2023 | 37670323 | PubTator, text mining | PubMed |
| α-catenin mechanosensitivity as a route to cytokinesis failure through sequestration of LZTS2. | bioRxiv | 2023 | 37662204 | PubTator, text mining | PubMed |
| Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug. | Acta Pharm Sin B | 2023 | 37655324 | PubTator, text mining | PubMed |
| Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury. | Neurotherapeutics | 2023 | 37653253 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| Production, Exacerbating Effect, and EV-Mediated Transcription of Hepatic CCN2 in NASH: Implications for Diagnosis and Therapy of NASH Fibrosis. | Int J Mol Sci | 2023 | 37629004 | PubTator, text mining | PubMed |
| Enantioselective in vitro metabolism of the herbicide diclofop-methyl: Prediction of toxicokinetic parameters and reaction phenotyping. | J Pharm Biomed Anal | 2023 | 37619294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=17